Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/18.BgH5HSOh.js ...

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, ...

Q1 2025 Management View CEO Beena Goldenberg highlighted Organigram's position as Canada's largest cannabis company by market share, emphasizing strong performance from flagship brands SHRED and ...

Reports Q1 adjusted EBITDA1 C$1.4M vs. C$0.1M in the prior year period. “This is an exciting time for Organigram (OGI) as we kick off Fiscal ...

Following the company’s first quarter results, Haywood analyst Neal Gilmer has cut his price target on Organigram.

Alliance Global Partners analyst Aaron Grey lowered the firm’s price target on Organigram (OGI) to C$3 from C$4.25 and keeps a Buy rating on ...

OrganiGram Holdings' loss widened and revenue growth missed expectations in the first fiscal quarter as the company integrates its acquisition of cannabis producer Motif Labs. The Canadian licensed ...

Management sees German medical market quadrupling as it awaits key EU certification and works to boost production capacity.

OrganiGram Holdings Inc. (OGI) on Tuesday reported a loss of $16.4 million in its fiscal first quarter. The Toronto-based company said it had a loss of 14 cents per share.

The Canadian cannabis producer missed revenue expectations but posted stronger margins as international sales surge.

Q1 2025 Earnings Call Transcript February 11, 2025 OrganiGram Holdings Inc. misses on earnings expectations. Reported EPS is $-0.2 EPS, expectations were $-0.03. Operator: Good morning. My name is ...